“…Based on case reports and our experience, Staphylococcus aureus, dermatophyte, and candidal infections occur not infrequently in patients with ichthyosis, although S aureus infections are less common than in those with moderate-to-severe AD. 99,[112][113][114][115][116] Even with an anti-IL-17 drug (secukinumab) for psoriasis, only about 1% of patients have mild-to-moderate mucocutaneous infections, predominantly candidal. 117,118 The reactive role of T H 17/IL-23 skewing to the barrier defects versus a primary pathogenic role in patients with ichthyosis can only be clarified through future studies with targeted antagonists, which include careful monitoring for mucocutaneous infections.…”